Marlene Debel - Net Worth and Insider Trading

Marlene Debel Net Worth

The estimated net worth of Marlene Debel is at least $5 Million dollars as of 2024-04-27. Marlene Debel is the EVP & Chief Risk Officer of MetLife Inc and owns about 77,638 shares of MetLife Inc (MET) stock worth over $5 Million. Details can be seen in Marlene Debel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Marlene Debel has not made any transactions after 2023-08-09 and currently still holds the listed stock(s).

Transaction Summary of Marlene Debel

To

Marlene Debel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Marlene Debel owns 2 companies in total, including MetLife Inc (MET) , and Raymond James Financial Inc (RJF) .

Click here to see the complete history of Marlene Debel’s form 4 insider trades.

Insider Ownership Summary of Marlene Debel

Ticker Comapny Transaction Date Type of Owner
MET MetLife Inc 2023-08-09 EVP & Chief Risk Officer
RJF Raymond James Financial Inc 2020-12-02 director

Marlene Debel Latest Holdings Summary

Marlene Debel currently owns a total of 1 stock. Marlene Debel owns 77,638 shares of MetLife Inc (MET) as of August 9, 2023, with a value of $5 Million.

Latest Holdings of Marlene Debel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MET MetLife Inc 2023-08-09 77,638 70.42 5,467,268

Holding Weightings of Marlene Debel


Marlene Debel Form 4 Trading Tracker

According to the SEC Form 4 filings, Marlene Debel has made a total of 3 transactions in MetLife Inc (MET) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in MetLife Inc is the sale of 9,391 shares on August 9, 2023, which brought Marlene Debel around $593,323.

Insider Trading History of Marlene Debel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Marlene Debel Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Marlene Debel Ownership Network

Ownership Network List of Marlene Debel

No Data

Ownership Network Relation of Marlene Debel


Marlene Debel Owned Company Details

What does MetLife Inc do?

Who are the key executives at MetLife Inc?

Marlene Debel is the EVP & Chief Risk Officer of MetLife Inc. Other key executives at MetLife Inc include EVP & Global Tech. & Ops. Bill Pappas , President & U.S. Business Ramy Tadros , and director & President & CEO Michel Khalaf .

MetLife Inc (MET) Insider Trades Summary

Over the past 18 months, Marlene Debel made 1 insider transaction in MetLife Inc (MET) with a net sale of 9,391. Other recent insider transactions involving MetLife Inc (MET) include a net sale of 34,857 shares made by Bill Pappas , a net sale of 77,661 shares made by Michel Khalaf , and a net sale of 29,401 shares made by Steven J Goulart .

In summary, during the past 3 months, insiders sold 51,486 shares of MetLife Inc (MET) in total and bought 0 shares, with a net sale of 51,486 shares. During the past 18 months, 158,342 shares of MetLife Inc (MET) were sold and 17 shares were bought by its insiders, resulting in a net sale of 158,325 shares.

MetLife Inc (MET)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

MetLife Inc Insider Transactions

No Available Data

Marlene Debel Mailing Address

Above is the net worth, insider trading, and ownership report for Marlene Debel. You might contact Marlene Debel via mailing address: Metlife, Inc., 200 Park Avenue, New York Ny 10166.

Discussions on Marlene Debel

No discussions yet.